H1B Report
Side-by-side comparison

WIPRO LIMITED vs Dana-Farber Cancer Institute

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
WIPRO LIMITED
NJRank #5FEIN 98-0154401
Entity B
Dana-Farber Cancer Institute
MARank #FEIN 04-2263040

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricWIPRO LIMITEDDana-Farber Cancer Institute
Total filings71,0221,840
Certified %8.45%24.73%
Denied %0.00%0.16%
Withdrawn %0.15%0.60%
Cert-withdrawn %0.58%5.65%
Rank#5
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateNJMA

Outcomes — WIPRO LIMITED

DOL case-status mix.

Outcome breakdown: Certified 92.0%, Cert-withdrawn 6.3%, Withdrawn 1.6%
Outcome breakdown
OutcomeShare
Certified92.0%
Cert-withdrawn6.3%
Withdrawn1.6%
Certified92.0%
Cert-withdrawn6.3%
Withdrawn1.6%

Outcomes — Dana-Farber Cancer Institute

DOL case-status mix.

Outcome breakdown: Certified 79.4%, Cert-withdrawn 18.1%, Withdrawn 1.9%, Denied 0.5%
Outcome breakdown
OutcomeShare
Certified79.4%
Cert-withdrawn18.1%
Withdrawn1.9%
Denied0.5%
Certified79.4%
Cert-withdrawn18.1%
Withdrawn1.9%
Denied0.5%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

WIPRO LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20103,018
FY20113,025
FY20126,933
FY20136,525
FY20148,008
FY201511,733
FY201610,233
FY20174,938
FY20186,036
FY20194,053
FY202094
FY2021128
FY202297
FY2023554
FY20242,296
FY20252,289
FY20261,062
Dana-Farber Cancer Institute
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY2010127
FY2011128
FY2012143
FY2013135
FY2014107
FY2015101
FY2016114
FY2017108
FY2018128
FY2019176
FY20200
FY20210
FY20220
FY2023104
FY2024162
FY2025199
FY2026108

Top 5 occupations — WIPRO LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.
WIPRO LIMITED vs Dana-Farber Cancer Institute — H-1B Sponsor Comparison · H1B Report